Genzyme Corporation
Biotech company reports 22% increase in fourth-quarter revenue
Published in Healthcare Mergers, Acquisitions and Ventures Week, February 11th, 2006
For the year, revenue grew 24% to $2.7 billion from $2.2 billion in the previous year.
Genzyme reported these and other preliminary, unaudited revenue figures in advance of a presentation by Chairman and CEO Henri A. Termeer at the JPMorgan 24th annual healthcare conference in San Francisco, California. The company will report full financial results for 2005 on February 15, 2006, when it will also provide additional financial guidance for 2006. Genzyme initially projects 2006 revenue of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Acacia Research Corporation
CombiMatrix to become independent public company - Acadia Pharmaceuticals, Inc.
Pharmaceutical company reports additional $10M equity investment by Sepracor - Advance Nanotech, Inc.
Nanotech firm appoints Claudio Marinelli as entrepreneur-in-residence - Advanced BioPhotonics Inc.
Medical imaging company restructures and reduces board of directors - Advanced BioPhotonics, Inc.
Imaging company closes on second financing milestone - Advanced Magnetics, Inc.
Imaging agent developer reports loss of $0.43 per share - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
